GTBPVSKALA• 3 Months (Normalized)
GTBP vs KALA (GT Biopharma Inc. vs KALA BIO Inc.)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+1513.64%
GT Biopharma Inc.
Normalized Baseline0.00%
KALA Performance $0.56
-73.21%
KALA BIO Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1586.85 pts
GTBP outperforming by 1586.85 percentage points
GTBPKALA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP KALA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | GTBP Price | GTBP Gain (%) | KALA Price | KALA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $7.10 | +1513.64% | $0.56 | -73.21% | +1586.85% |
| Sep 22, 2026 | $- | $0.60 | -71.34% | - | |
| Sep 21, 2026 | $7.18 | +1531.82% | $0.56 | -73.21% | +1605.03% |
| Sep 18, 2026 | $7.16 | +1527.27% | $0.54 | -74.21% | +1601.48% |
| Sep 17, 2026 | $7.49 | +1602.27% | $0.57 | -72.97% | +1675.24% |
| Sep 16, 2026 | $7.81 | +1675.00% | $0.52 | -75.02% | +1750.02% |
| Sep 15, 2026 | $9.00 | +1945.45% | $0.51 | -75.69% | +2021.14% |
| Sep 14, 2026 | $11.63 | +2543.18% | $0.54 | -74.11% | +2617.29% |
| Sep 11, 2026 | $8.61 | +1856.82% | $0.57 | -72.63% | +1929.45% |
| Sep 10, 2026 | $6.18 | +1304.55% | $0.56 | -73.06% | +1377.61% |
| Sep 09, 2026 | $5.98 | +1259.09% | $0.56 | -73.35% | +1332.44% |
| Sep 08, 2026 | $- | $0.54 | -74.26% | - | |
| Sep 04, 2026 | $0.24 | -45.23% | $0.51 | -75.74% | +30.51% |
| Sep 03, 2026 | $0.25 | -42.73% | $0.56 | -73.16% | +30.43% |
| Sep 02, 2026 | $0.28 | -35.68% | $0.52 | -74.98% | +39.30% |
Page 1 of 5